Skip to content
lifestyle.ebusinessplanet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Oryzon Genomics, S.A.
ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in Extensive Stage Small Cell Lung Cancer
March 8, 2026
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
February 27, 2026
ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan
February 2, 2026
←
Previous Page
1
2